Results 11 to 20 of about 1,663 (174)

Intravitreal ziv-aflibercept for macular edema following retinal vein occlusion [PDF]

Clinical Ophthalmology, 2016
Remya Paulose,1 Jay Chhablani,1 Chintan J Dedhia,1 Michael W Stewart,2 Ahmad M Mansour3,4 1Smt. Kanuri Santhamma Centre for Vitreoretinal Diseases, LV Prasad Eye Institute, Hyderabad, India; 2Department of Ophthalmology, Mayo Clinic, Jacksonville, FL ...
Paulose R, Chhablani J, Dedhia CJ, Stewart MW, Mansour AM   +4 more
doaj   +9 more sources

Phase I study of sapanisertib (CB‐228/TAK‐228/MLN0128) in combination with ziv‐aflibercept in patients with advanced solid tumors [PDF]

Cancer Medicine
Background Sapanisertib is a potent ATP‐competitive, dual inhibitor of mTORC1/2. Ziv‐aflibercept is a recombinant fusion protein comprising human VEGF receptor extracellular domains fused to human immunoglobulin G1.
Niamh Coleman, Bettzy Stephen, Siqing Fu, Daniel Karp, Vivek Subbiah, Jordi Rodon Ahnert, Sarina A. Piha‐Paul, John Wright, Senait N. Fessahaye, Fengying Ouyang, Bulent Yilmaz, Funda Meric‐Bernstam, Aung Naing   +12 more
doaj   +5 more sources

Intravitreal ziv-aflibercept in diabetic vitreous hemorrhage [PDF]

International Journal of Retina and Vitreous, 2020
Background To evaluate the safety and efficacy of intravitreal ziv-aflibercept (IVZ) in the management of vitreous hemorrhage (VH) in eyes with previously lasered proliferative diabetic retinopathy (PDR).
Ahmad M. Mansour, Mohammed Ashraf, Khalil M. El Jawhari, Michel Farah, Ahmed Souka, Chintan Sarvaiya, Sumit Randhir Singh, Alay Banker, Jay Chhablani   +8 more
doaj   +7 more sources

Ziv-aflibercept in Diabetic Macular Edema: Relation of Subfoveal Choroidal Thickness with Visual and Anatomical Outcomes [PDF]

Journal of Ophthalmic & Vision Research, 2023
Purpose: To evaluate the effects of intravitreal ziv-aflibercept injections (IVZ) on subfoveal choroidal thickness (SCT) as well as on central macular thickness (CMT) and on best corrected visual acuity (BCVA) changes in eyes with center-involved ...
Siamak Moradian, Masoud Soheilian, Mahsan Asadi, Abdolreza Baghi, Hamid Safi, Seyed-Hossein Abtahi   +5 more
doaj   +6 more sources

Bevacizumab versus ziv-aflibercept in branch retinal vein occlusion [PDF]

Indian Journal of Ophthalmology, 2019
Purpose: To compare the effectiveness of treatment with intravitreal bevacizumab (IVB) and ziv-aflibercept (IVZ) in patients with macular edema (ME) post-branch retinal vein occlusion (BRVO).
Imoro Z Braimah, Sumit Randhir Singh, Bhushan Uplanchiwar, Ahmad M Mansour, Jay Chhablani   +4 more
doaj   +5 more sources

Disease Control With FOLFIRI Plus Ziv-aflibercept (zFOLFIRI) Beyond FOLFIRI Plus Bevacizumab: Case Series in Metastatic Colorectal Cancer (mCRC) [PDF]

Frontiers in Oncology, 2019
Background: The prognosis of patients with metastatic colorectal cancer (mCRC) is poor, especially after failure of initial systemic therapy. The VELOUR study showed modestly prolonged overall survival (OS) with ziv-aflibercept plus 5-fluorouracil ...
Wafik S. El-Deiry, Wafik S. El-Deiry, Arthur Winer, Michael Slifker, Stanford Taylor, Blythe J. S. Adamson, Neal J. Meropol, Eric A. Ross, Eric A. Ross   +8 more
doaj   +6 more sources

Effectiveness of the Use of Three-Dose Intravitreal Ziv-Aflibercept in the Management of Diabetic Macular Edema in a Real-Life Setting [PDF]

Clinical Ophthalmology, 2023
Fernando Munayco-Guillén,1,2 Miguel Angel Vazquez-Membrillo,1,2 Marlon Rafael Garcia-Roa,1,2 Jhony Alberto De La Cruz-Vargas,3 Herney Andrés García-Perdomo,4 Rafael Pichardo-Rodriguez3 1Department of Retina and Vitreous Surgery, Instituto Mexicano de ...
Munayco-Guillén F, Vazquez-Membrillo MA, Garcia-Roa MR, De La Cruz-Vargas JA, García-Perdomo HA, Pichardo-Rodriguez R   +5 more
doaj   +4 more sources

The sterility, stability and efficacy of repackaged ziv-aflibercept for intravitreal administration [PDF]

Scientific Reports, 2022
To evaluate the sterility, stability, and efficacy of repackaged ziv-aflibercept in 1-mL plastic tuberculin syringes for intravitreal injection after storage for up to 90 days at controlled (4 °C) and ambient (25.8 °C) temperature.
Jakkrit Juhong, Pear Ferreira Pongsachareonnont, Thanapong Somkijrungroj, Apivat Mavichak, Adisai Varadisai, Pajaree Chariyavilaskul, Tanittha Chatsuwan, Thitima Benjachat Suttichet, Kittisak Kulvichit   +8 more
doaj   +5 more sources

A combination of suprachoroidal injection of triamcinolone using a custom-made needle and intravitreal Ziv-aflibercept every eight weeks to manage naïve/denovo central DME: a single-center retrospective case series [PDF]

International Journal of Retina and Vitreous
Background Previous studies have shown promising effects of combining intravitreal bevacizumab and suprachoroidal injection of triamcinolone acetonide in treating DME. However, further research is needed.
Ameen Marashi, Marwa Baba, Sedra Abu Ghedda, Mohammad Nour Kitaz, Aya Zazo   +4 more
doaj   +4 more sources

12-month outcomes of ziv-aflibercept for neovascular age-related macular degeneration in eyes previously treated with aflibercept [PDF]

Indian Journal of Ophthalmology
Purpose: To investigate the 12-month outcomes of ziv-aflibercept for neovascular age-related macular degeneration (nAMD) in eyes previously treated with aflibercept.
Wajiha J Kheir, Mahdi Hassoun, Rola N Hamam, Ziad Fayez Bashshur   +3 more
doaj   +3 more sources